First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC)
2024; Elsevier BV; Volume: 85; Linguagem: Inglês
10.1016/s0302-2838(24)01471-4
ISSN1873-7560
AutoresChiara Mercinelli, Giuseppe Basile, Daniele Raggi, Antonio Cigliola, Valentina Tateo, Damiano Alfio Patanè, E. Crupi, T. Costa De Padua, M. Colecchia, Renzo Colombo, Marco Moschini, Chiara Re, G. Avesani, G. Brembilla, Francesco De Cobelli, Alberto Briganti, Dean C. Pavlick, Jeffrey S. Ross, Francesco Montorsi, Andrea Necchi,
Tópico(s)Esophageal Cancer Research and Treatment
Referência(s)